TAS-120: Futibatinib in Advanced Cholangiocarcinoma with FGFR2 Fusions By Steve|2025-06-30T13:38:26+10:00December 13th, 2024|Categories: All, Treatments & Trials|Tags: FGFR2, TAS120| Read More 0
Orphan Drug for Intrahepatic Bile Duct Cancer By Steve|2024-12-13T19:28:45+10:00December 13th, 2024|Categories: All, Clinical Trials, Treatments & Trials|Tags: PLT012| Read More 0
World-First Pilot Study Explores New Cholangiocarcinoma Treatment By Steve|2024-12-13T18:18:15+10:00December 13th, 2024|Categories: All, Clinical Trials|Tags: AGITG, durvalumab, PARP. Olaparib| Read More 0
Immunotherapy and Chemotherapy Combinations for Cholangiocarcinoma By Steve|2024-11-25T15:28:06+10:00November 18th, 2024|Categories: All, Combinations, Treatments & Trials|Tags: Checkpoint Pathway, Gem/Cis, PD-1 Checkpoint inhibitors, PD-L1 Checkpoint Inhibitors| Read More 0
The Luckiest Unlucky Guy – The Matt Reidy Story By Steve|2024-11-10T17:48:42+10:00November 10th, 2024|Categories: All, Patient Story|Tags: Keytruda, USA| Read More 1
Evaluating the New Cholangiocarcinoma Vaccine Trial: A Patient-Centric Analysis” By Steve|2025-08-10T13:07:18+10:00October 30th, 2024|Categories: All, Clinical Trials, Treatments & Trials|Tags: vaccine| Read More 0
Graeme Holmes By Steve|2024-10-14T16:54:02+10:00October 10th, 2024|Categories: Remembrance|Tags: remembrance| Read More 0
Fixing Broken IDH1 in Cholangiocarcinoma: How Inhibitors Are Changing the Fight By Steve|2024-10-13T19:18:45+10:00October 1st, 2024|Categories: All, Q&A, Z-Legacy|Tags: IDH1, IDH2, Mitochondria| Read More 0
IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials By Steve|2024-10-14T16:43:27+10:00September 25th, 2024|Categories: All, Q&A, Z-Legacy|Tags: ATR Inhibitors, clinical, Clinical Trial, iCCA, IDH1 Mutation, PARP Inhibitors, RAD-3, Shruti| Read More 0
Michael Flannery: Life Goes On: My Journey with Cholangiocarcinoma By Steve|2024-10-13T19:18:48+10:00September 24th, 2024|Categories: All, Z-Legacy|Tags: Michael Flannery, patient| Read More 0